DK0861837T3 - Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK0861837T3
DK0861837T3 DK98400469T DK98400469T DK0861837T3 DK 0861837 T3 DK0861837 T3 DK 0861837T3 DK 98400469 T DK98400469 T DK 98400469T DK 98400469 T DK98400469 T DK 98400469T DK 0861837 T3 DK0861837 T3 DK 0861837T3
Authority
DK
Denmark
Prior art keywords
alkyl
aminoindan
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK98400469T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0861837T3 publication Critical patent/DK0861837T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98400469T 1997-02-27 1998-02-27 Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse DK0861837T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0861837T3 true DK0861837T3 (da) 2004-08-16

Family

ID=9504253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98400469T DK0861837T3 (da) 1997-02-27 1998-02-27 Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Country Status (18)

Country Link
US (1) US5968954A (da)
EP (1) EP0861837B1 (da)
JP (1) JPH10237071A (da)
CN (1) CN1090627C (da)
AT (1) ATE265451T1 (da)
AU (1) AU725756B2 (da)
BR (1) BR9800763A (da)
CA (1) CA2231025C (da)
DE (1) DE69823411T2 (da)
DK (1) DK0861837T3 (da)
ES (1) ES2219853T3 (da)
FR (1) FR2760014B1 (da)
HU (1) HU224312B1 (da)
NO (1) NO314307B1 (da)
NZ (1) NZ329853A (da)
PL (1) PL190240B1 (da)
PT (1) PT861837E (da)
ZA (1) ZA981680B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI274750B (en) * 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
MXPA03006250A (es) 2001-01-16 2003-09-22 Astrazeneca Ab Compuestos heterociclicos terapeuticos.
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
WO2006062063A1 (ja) * 2004-12-08 2006-06-15 Astellas Pharma Inc. ピペリジン誘導体及びその製造法
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP0861837B1 (fr) 2004-04-28
ES2219853T3 (es) 2004-12-01
NO980803L (no) 1998-08-28
CN1090627C (zh) 2002-09-11
CA2231025A1 (fr) 1998-08-27
FR2760014A1 (fr) 1998-08-28
US5968954A (en) 1999-10-19
BR9800763A (pt) 1999-12-07
PL190240B1 (pl) 2005-11-30
NO980803D0 (no) 1998-02-26
ZA981680B (en) 1998-09-04
JPH10237071A (ja) 1998-09-08
ATE265451T1 (de) 2004-05-15
CN1194983A (zh) 1998-10-07
PT861837E (pt) 2004-07-30
HUP9800422A1 (hu) 1999-12-28
AU5635998A (en) 1998-09-03
HU224312B1 (hu) 2005-07-28
EP0861837A1 (fr) 1998-09-02
DE69823411T2 (de) 2005-02-17
DE69823411D1 (de) 2004-06-03
CA2231025C (fr) 2003-09-16
HK1014945A1 (en) 1999-10-08
AU725756B2 (en) 2000-10-19
PL324982A1 (en) 1998-08-31
FR2760014B1 (fr) 1999-04-09
HU9800422D0 (en) 1998-04-28
NZ329853A (en) 1999-01-28
NO314307B1 (no) 2003-03-03

Similar Documents

Publication Publication Date Title
BR9803295A (pt) preparos e composições farmacêuticas contendo os mesmos.
ES2091834T3 (es) Compuestos aromaticos.
DK0428437T3 (da) 1,2-benzisoxazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
MX9204137A (es) Derivados de 5-aril-isoxazol, composicion herbicida que los contiene y procedimiento para su preparacion.
ES530902A0 (es) Procedimiento para preparar derivados de piperazina
NO308659B1 (no) Nye 4,6-diarylpyrimidin-derivater, salter derav, anvendelse derav og farmasøytisk preparat
ES2123652T3 (es) 7-(2-aminoetil)-benzotiazolonas.
NO980803D0 (no) Nye 2-aminoindanforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholder dem
ECSP034917A (es) Nuevos derivados de acido sulfonico
DE69802249D1 (de) Neue N-Aryl-2-hydroxy-alkylamide
HRP20000508B1 (hr) Supstituirani 2-benzilamino-2-fenil-acetamidni spojevi
NO975121L (no) Nye heterocykliske aminometylforbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
DK1042326T3 (da) Nye acronycinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
NO981566L (no) Nye aminoforbindelser av 6,7,8,9-tetrahydro-cyklopenta[a]naftalen og av 2,3-dihydro-cyklopenta[e]inden, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger som inneholder dem
DK0765877T3 (da) 5,6,7,8-tetrahydronaphtho-[2,3-b]-furan- og indano-[5,6-b]-furan-aminoforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
HUP9800687A1 (hu) N-aril-piperidin-származékok, eljárás előállításukra, és e vegyületeket tartalmazó gyógyszerkészítmények